These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10585787)

  • 1. Estimating the true cost of amphotericin B.
    Rex JH; Walsh TJ
    Clin Infect Dis; 1999 Dec; 29(6):1408-10. PubMed ID: 10585787
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?
    Schneemann M; Bachli EB
    Clin Infect Dis; 2004 Jan; 38(2):303-4; author reply 306-7. PubMed ID: 14699468
    [No Abstract]   [Full Text] [Related]  

  • 4. Amphotericin B deoxycholate: time to retire our old standard?
    Gallagher JC
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):313-6. PubMed ID: 15954845
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect on amphotericin B lipid complex use of a clinical decision support system for computerized prescriber order entry.
    Collins CD; Pedersen CA; Schneider PJ; Miller AS; Sierawski SJ; Roux RK
    Am J Health Syst Pharm; 2004 Jul; 61(13):1395-9. PubMed ID: 15287238
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
    Drew R
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():36-44. PubMed ID: 16713192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate.
    Garnacho-Montero J; Ortiz-Leyba C; García Garmendia JL; Jiménez Jiménez F
    Clin Infect Dis; 1998 Apr; 26(4):1016. PubMed ID: 9564508
    [No Abstract]   [Full Text] [Related]  

  • 8. ABELCET treatment.
    Boyle JA; Swenson CE
    J Clin Pharmacol; 1999 Apr; 39(4):427-8. PubMed ID: 10197303
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature.
    Martino R
    Curr Med Res Opin; 2004 Apr; 20(4):485-504. PubMed ID: 15119986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
    Winston DJ; Schiller GJ
    Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality rates in comparative trials of formulations of amphotericin B.
    Frothingham R
    Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201
    [No Abstract]   [Full Text] [Related]  

  • 12. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
    Virata SR; Kylstra JA; Brown JC; Wohl DA; Cohen MS
    Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amphotericin B--lipid complex].
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):53. PubMed ID: 9147519
    [No Abstract]   [Full Text] [Related]  

  • 14. Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole.
    Cook PP
    South Med J; 2001 May; 94(5):548-9. PubMed ID: 11372815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication averts an overdose.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Mar; 98(3):12. PubMed ID: 9536168
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid amphotericin B combinations; 'la crème de la crème'?
    Hay RJ
    J Infect; 1999 Jul; 39(1):16-20. PubMed ID: 10468123
    [No Abstract]   [Full Text] [Related]  

  • 17. Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.
    Pappas PG
    Clin Infect Dis; 2005 May; 40 Suppl 6():S379-83. PubMed ID: 15809923
    [No Abstract]   [Full Text] [Related]  

  • 18. Amphotericin B: is a lipid-formulation gold standard feasible?
    Spellberg B; Witt MD; Beck CK
    Clin Infect Dis; 2004 Jan; 38(2):304-5; author reply 306-7. PubMed ID: 14699470
    [No Abstract]   [Full Text] [Related]  

  • 19. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Schneemann M; Imhof A
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675094
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe and common side-effects of amphotericin B lipid complex (Abelcet).
    Ringdén O; Jønsson V; Hansen M; Tollemar J; Jacobsen N
    Bone Marrow Transplant; 1998 Oct; 22(7):733-4. PubMed ID: 9818706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.